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promoted in osteopathy and provide data which can inform policy decisions 
within the healthcare system.  
Objective: Identify, appraise and synthesise the evidence from 
comparative effectiveness and economic evaluation research involving OMT. 
Design: Systematic literature review.  
Methods:  A database search was conducted using CINAHL, PubMed, PEDro, 
AMED, SCOPUS and OSTMED.DR, from their inception to May 2015. Two 
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Cochrane risk of bias tool and appraised using the Good Reporting of 
Comparative Effectiveness (GRACE) principles. Identified economic studies 
were assessed with the Consolidated Health Economic Evaluation Reporting 
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The comparative effectiveness studies reported outcomes for varied health 
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differences in the quality of reporting were evident.  
Conclusion: Despite some positive findings, published comparative 
effectiveness and health economic studies in OMT are of insufficient 
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Dear Dr Ann Moore,  
Please find attached the article ‘Osteopathic manipulative treatment: A systematic 
review and critical appraisal of comparative effectiveness and health economics 
research’, for exclusive consideration for publication in the Manual Therapy Journal.   
This manuscript presents the first review of the comparative effectiveness and cost 
effectiveness research in osteopathic manipulative treatment. The review offers a critical 
appraisal of existing research and provides recommendations to strengthen future research 
in this important field. 
All the authors have made substantial contributions to this manuscript. Drs Amie Steel and 
Tobias Sundberg conceptualised the study and, in collaboration with Ms Rebecca Reid, 
developed the overall protocol for the review. Ms Reid undertook the search for manuscripts 
in line with the developed protocol and Dr Sundberg extracted the data from included papers 
with sample verification of both stages by Dr Steel. Drs Lesley Ward and Felicity Bishop 
were responsible for the Risk of Bias assessments and Dr Ward collaborated with Dr Holger 
Cramer to complete the appraisal of included papers according to the GRACE guidelines. 
Assessment of papers to determine their alignment with comparative effectiveness principles 
in line with the PRECIS-2 tool was undertaken by Drs Steel and Sundberg. Evaluation of 
health economic research manuscripts in accordance with the CHEERS statement was 
completed by Dr Steel and Dr Jon Wardle. Dr Matthew Leach contributed substantially to the 
interpretation of findings and recommendations for future research. All authors contributed to 
the drafting, editing and finalisation of the submitted manuscript. 
 
Letter to the Editor
We feel that the significance of our findings will be of particularly interest to the international 
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Osteopathic manipulative treatment: A systematic 
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effectiveness and health economics research 
 
ABSTRACT 
Background: In recent years, evidence has emerged regarding the effectiveness of 
osteopathic manipulative treatments (OMT). Despite growing evidence in this field, there is 
need for appropriate research designs that effectively reflect the person-centred system of 
care promoted in osteopathy and provide data which can inform policy decisions within the 
healthcare system.  
Objective: Identify, appraise and synthesise the evidence from comparative effectiveness 
and economic evaluation research involving OMT. 
Design: Systematic literature review.  
Methods:  A database search was conducted using CINAHL, PubMed, PEDro, AMED, 
SCOPUS and OSTMED.DR, from their inception to May 2015. Two separate searches were 
undertaken to identify original research articles encompassing the economic evaluation and 
comparative effectiveness of OMT. Identified comparative effectives studies were evaluated 
using the Cochrane risk of bias tool and appraised using the Good Reporting of Comparative 
Effectiveness (GRACE) principles. Identified economic studies were assessed with the 
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) guidelines. 
Results: Sixteen studies reporting the findings of comparative effectiveness (n=9) and 
economic evaluation (n=7) research were included. The comparative effectiveness studies 
reported outcomes for varied health conditions and the majority (n=6) demonstrated a high 
risk of bias. The economic evaluations included a range of analyses and considerable 



































































Conclusion: Despite some positive findings, published comparative effectiveness and 
health economic studies in OMT are of insufficient quality and quantity to inform policy and 
practice.  High quality, well-designed, research that aligns with international best practice is 
greatly needed to build a pragmatic evidence base for OMT. 
Keywords: osteopathy, osteopathic manipulative treatment, comparative effectiveness 
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Osteopathic healthcare is a holistic person-centred system of care aligned with the 
philosophy, principles of practice and application of osteopathic manipulative treatment 
(OMT) (1). While OMT can be prescribed for the management of various health conditions, it 
is most commonly indicated for the care of painful disorders such as low back pain (2), 
headaches (3), and neck pain (4). In addition to OMT, osteopathic practitioners may also 
prescribe other medical therapies (including pharmaceuticals) depending on the medico-
legal and regulatory standards of the country and scope of osteopathic training and practice 
(1, 5). Osteopathic healthcare has diverse representation across health systems 
internationally, ranging from full integration within conventional health care systems (i.e. in 
the US), through to semi-integration as allied and complementary health care therapists (i.e. 
in many European and Australasian countries) (1). Nonetheless, the primary shared 
component of all streams of osteopathic practice is OMT applied with an understanding of 
the relationship between the structure and function of the human body (1).  
The prevalence of osteopathic healthcare use has been reported at less than 5% of the 
general population in Australia (6) and as high as 16% in the United States (7). However, 
higher rates of use in Australia are found amongst specific populations such as the middle-
aged (16%) (8) and pregnant women (6.2%) (9). The use of osteopathic services is also 
much higher amongst individuals with specific health conditions, for example 13.4% of UK 
adults with back pain (10). This suggests that there is modest demand for osteopathic 
healthcare services, at least in Western countries. 
Research investigating the effectiveness of osteopathic treatments has intensified over the 
past decade. Current evidence from randomised controlled trials (RCTs) and systematic 
reviews of RCTs suggests that osteopathy-related interventions are effective in improving 
outcomes in patients with back pain (11), neck pain (12), sciatica (13), chronic obstructive 
pulmonary disease (14), irritable bowel syndrome (15, 16) and various paediatric conditions 




































































concerns have been raised regarding the applicability of the explanatory RCT to everyday 
clinical practice (REF). These concerns have led to the promotion of comparative 
effectiveness research (CER) - a pragmatic research design generating evidence that can 
be more efficiently translated into patient care and health policy (19). CER is defined as “the 
generation and synthesis of evidence that compares the benefits and harms of alternative 
methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the 
delivery of care” (20). Suggested key elements of CER include (a) direct comparisons of 
active treatments; (b) study patients, clinicians and interventions that are representative of 
usual practice; and (c) a focus on helping patients, clinicians and policy makers to make 
informed choices (21). While CER has been used to investigate OMT (22, 23), such studies 
have not yet been subject to systematic review that specifically focusses on OMT, and so 
the contribution of CER to the evidence-base in osteopathy is yet to be established. 
CER focuses not only on whether an intervention makes an impact under “real-world” 
conditions, but also on whether an intervention is beneficial in relation to the resources it 
consumes (18). This latter feature fits within the broad field of health economics through 
which policy makers attempt to manage the rise of health care expenditure by prioritizing 
between competing health care interventions based on value for money (24). Accordingly, 
health economic evaluations are crucial elements in political decision-making regarding the 
reimbursement and funding of health services (24). Economic evaluation of health 
interventions, such as osteopathic care, can be undertaken based either on clinical trial data 
or the modelling of data from a range of data sources (24). Whilst there have been some 
attempts to understand the cost-effectiveness of health services encompassing osteopathic 
healthcare, such as spinal manipulation (25) or manual therapy more generally (26), the 
findings of these studies have not yet provided firm conclusions regarding the cost 
effectiveness of osteopathic care as a discrete treatment option. Furthermore, cost-
effectiveness studies in OMT have not previously been reviewed in relation to CER, despite 




































































With this in mind, this paper presents the first critical systematic review of comparative 
effectiveness research and health economic evaluations of OMT. The aim was to review and 
critically appraise comparative effectiveness and health economic research on OMT.  The 
objectives were to elucidate the contribution that these research approaches can make to 
the OMT evidence-base, to identify strengths and limitations of existing studies, and to make 
recommendations for improving future studies using CER and health economic approaches. 
MATERIALS AND METHODS 
A comprehensive search of the literature was undertaken to identify published original 
research examining the comparative-effectiveness and health economics of OMT. Standard 
systematic review techniques were followed in accordance with the PRISMA statement (27) 
Search strategy 
An initial search was conducted of the following databases, from their inception to May 2015: 
CINAHL, PubMed, PEDro, AMED, SCOPUS and OSTMED.DR. Two distinct searches were 
undertaken in each database; one focusing on the economic evaluation of OMT, and the 
other on the comparative effectiveness of OMT. Shared search terms for both searches 
included osteopath*, random*, clinical trial, manipul*, manual therapy, and manual medicine. 
The term comparative effectiveness was applied to the search for research articles 
examining the comparative effectiveness of OMT. Likewise, cost* was used to identify 
papers exploring health economics. To ensure a broad range of articles were identified, 
manual searching was also conducted by reviewing references from existing review articles 
located through the database search in September 2015.  
Inclusion and exclusion criteria 
Articles were excluded if they did not present original empirical data, were not written in 
English, and did not examine OMT as a system of care. Articles were included if they 
evaluated health economic outcomes of OMT or compared the effectiveness of OMT with 




































































to the condition). No limits were placed on date of publication. Articles were screened, short-
listed and selected for data extraction by R.R. with sample verification of identified 
references undertaken by A.S. throughout the screening process. Any disagreements were 
resolved by discussion until consensus was reached. The full literature search processes for 
comparative effectiveness and health economic studies are outlined in Figures 1 and 2 
respectively.  
Data extraction 
Data were extracted by one investigator (T.S.) and verification of extracted data undertaken 
by another investigator (A.S.). Discussion was used to reach consensus in case of any 
disagreements. Data were extracted in accordance with the template provided by the 
Cochrane handbook guidelines (28) and modified for the purposes of this review to include 
information on methods, participants, intervention and outcomes.  
Critical analysis 
Risk of Bias 
Comparative effectiveness articles were independently evaluated for risk of bias by two 
investigators (L.W., F.B.) using criteria outlined in the Cochrane Handbook for Systematic 
Reviews (29). The Cochrane risk of bias tool was used to assess the domains of selection 
bias (random sequence generation, allocation concealment), performance bias (blinding of 
personnel and participants), detection bias (blinding of outcome assessment), attrition bias 
(drop-outs), reporting bias (selective reporting of outcomes), and any other sources of bias 
as identified by the reviewers. Ratings were compared (73% agreement, kappa = 0.60) and 
differences were resolved through discussion in order to reach consensus.  
Appraisal of comparative effectiveness studies 
Articles reporting comparative effectiveness research were scored using the PRagmatic-
Explanatory Continuum Indicator Summary-2 (PRECIS-2) tool (30) and independently 




































































(A.S., T.S.). All papers identified through PRECIS-2 categorisation as reporting 
observational studies were assessed in accordance with the Good Research for 
Comparative Effectiveness (GRACE) principles (H.C., L.W)  (31).  
Appraisal of health economic studies 
The quality of included health economics articles was assessed in accordance with the 
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (32). 
The CHEERS statement is intended to optimise reporting guidance for economic evaluations 
via a checklist that is subdivided into six main categories: (1) title and abstract; (2) 
introduction; (3) methods; (4) results; (5) discussion; and (6) other. The checklist consists of 
24 items, however one item was excluded from our analysis (i.e. item 12: “measurement and 
valuation of preference based outcomes”) as the item is optional and was not applicable to 
any of the included studies. Each paper was compared against the CHEERS checklist by 
two authors (A.S., J.W.) and awarded a score out of 23. Any differences between rater 
scores were discussed and a consensus decision made.  
Data analysis 




The outcomes of the literature search for health economics analyses (n=8) (33-40) and 
comparative effectiveness research (n=8) (41-48) of OMT are presented in Figures 1 and 2, 
respectively. A total of 16 papers reported on the findings of 15 studies, with one study 
reporting two smaller yet distinct analyses (39, 40). Research from North America dominated 
the included studies with 10 papers originating from the United States (35-38, 42, 44-48) and 
one from Canada (41). Studies originating from the United Kingdom (33, 39, 40, 43) and 




































































sampled adult participants, with a quarter (n=4) involving children. Sample sizes varied 
substantially between studies, from 29 (41) to 1556 (35) participants (mean = 276; median 
=90). However, when retrospective clinical audits (n=2) were excluded, the sample size 
range narrowed considerably (i.e. 29 to 178 participants; mean = 89; median = 58). 
Headache (38, 41), neck (39, 40, 47) and back pain (35, 39, 40, 42, 43, 46) were the most 
common conditions examined in the included studies; other conditions included otitis media 
(48), spastic cerebral palsy (44, 45), pancreatitis (37) and preterm birth (34). Studies were 
undertaken in either community clinics (39-46, 48) or hospital environments (34-38, 47, 49). 
Results of the selected studies are displayed in Table 1.  
Comparative effectiveness research 
The comparative effectiveness studies (n=8) identified in this review included both adult and 
paediatric populations. The characteristics of the interventions used in these studies were 
either OMT with manipulation or OMT in combination with another intervention (i.e. 
progressive muscle relaxation, or herbal medicine). OMT was compared with standard care 
in five studies (42, 44-47), sham OMT in two studies (46, 48), acupuncture (44, 45) in two 
studies, and pharmaceuticals (47) and physiotherapy (43) in one study each. Where studies 
included sham OMT, at least one arm of the study included access to standard care or a 
comparative treatment intervention. Some studies described participants as accessing no 
care or a wait-list control but the studies specified participants to continue accessing usual 
care through the study period (46) and as such these studies were considered as using 
‘standard care’ as the comparator.  
Outcomes of comparative effectiveness research 
In line with the heterogeneous characteristics of the identified studies, the reported 
outcomes of OMT were also mixed. Research examining the effectiveness of OMT for the 
management of low back pain found no significant difference in benefit when compared with 
standard allopathic treatment (42), group exercise or physiotherapy (43), or sham 




































































to OMT in a study conducted in an emergency department, whereby both groups reported a 
similarly significant reduction in pain intensity (47). Significant improvement in mobility 
measures were reported for OMT treatment of spastic cerebral palsy when compared with 
wait-list control or acupuncture (45). Similarly, OMT treatment was found to reduce the 
occurrence of headache-free days for individuals experiencing tension headaches, but with 
no statistically significant difference in the intensity of the headaches, when compared with 
progressive muscle relaxation exercises (41).  
Critical appraisal of comparative effectiveness research 
The majority of the eight studies identified as comparative effectiveness studies of OMT 
were assessed as having a high risk of bias for blinding of participants (6 studies, 75%) and 
blinding of outcome assessment (4 studies, 50%), and unclear risk of bias for selective 
outcome reporting (6 studies, 75%) and allocation concealment (5 studies, 63%). The only 
domain with an overall low risk of bias across the eight studies was random sequence 
generation (6 studies, 75%). The two studies with the lowest overall risk of bias were 
characterised as having robust randomisation, well-reported allocation concealment, blinded 
outcome assessors, and low rates of attrition (45, 48). The study with the lowest risk of bias 
was undertaken by Wahl et al (48). The risk of bias assessment for all studies is reported in 
Table 2.  
According to the PRECIS-2 scores (presented in Table 2), all comparative effectiveness 
studies were identified as ‘observational’ rather than ‘explanatory’ research. McReynolds et 
al (47) and Andersson et al (42) most closely fit the criteria for an ‘observational’ 
comparative effectiveness study while Liccardone (46) most closely aligned with the 
characteristics of an explanatory randomised-control trial study design. The study design 
element which most consistently supported pragmatic comparative effectiveness research 
was the setting of the included studies as they were all conducted in a real-life clinical 
environment. The factors that detracted from these studies aligning with real-life clinical 




































































in the delivery of osteopathic treatments and the requirement that clinicians adhere to a 
structured treatment protocol (results not shown).  
Compliance with the GRACE statement checklist differed across all studies (see Table 3). 
Three studies (42, 46, 47) complied with 10 of the 12 checklist items and one study complied 
with 9 of the 12 checklist items. The lowest attributed score was for the study by Wahl et al 
(48), which complied with 3 of the 12 items. All studies were non-compliant with two items of 
the GRACE checklist: details of treatment were not adequately recorded; and meaningful 
analyses were not conducted to test key assumptions on which the primary results were 
based. Other common areas of non-compliance included failing to restrict the study 
population to new initiators of treatment, and overlooking important covariates or 
confounding variables in the study design or analysis.  
Economic analysis research 
Study characteristics 
The included economic papers (n=8) represented a range of economic analyses, including 
costing studies (33, 35, 38, 40), cost-effectiveness analyses (34, 36, 37) and cost-utility 
analysis (39). Two papers reported a cost of care (40) and cost utility analysis (39) from the 
same study. The outcome measure utilised across all three cost-effectiveness studies was 
length of hospital stay.  
Study outcomes 
The identified studies reported a reduction in costs for OMT when compared with standard 
care for the management of neonatal preterm birth recovery (34), lumbar disc herniation-
associated sciatica (49), and posterolateral posthoractomy recovery (36), but not for the 
management of neck or back pain. The ‘cost of treatment’ studies identified either direct 
cost-savings in the case of lumber disc herniation-associated sciatica (reflecting a savings of 
£300 per patient) (33), or a reduced cost of care when patients with low back pain (35) or 




































































care. Reduction in the length of hospital stay was reported in posterolateral post-
thoracotomy recovery (for patients with lung decortication only) (-6.4 days) (36), pancreatitis 
(-4.5 days) (37), and neonatal preterm birth recovery (-5.9 days) (34). The latter study 
involving preterm infants was the only study to extrapolate a cash value to this outcome, 
proposing a net saving of -€2724.91 per infant (34). The only cost-utility analysis identified 
reported improved pain and quality of life in patients with neck or back pain (39, 40) at a cost 
of £3760 per quality-adjusted life year (QALY) gained. 
Critical appraisal of economic analysis of osteopathic manipulative techniques 
There were substantial differences in the quality of reporting of the six included papers (from 
five discrete studies) evaluating the cost-effectiveness of osteopathic manual therapies 
when assessed against the CHEERS guidelines (see Table 4). Two papers were unable to 
be assessed against CHEERS guidelines as they failed to report monetary outcomes from 
their economic analyses (36, 37). The majority of the included papers effectively reported 
the background and objectives (5/6), target population and subgroups (5/6), estimation of 
resources and costs (5/6), and the discussion of the findings (5/6). The areas of greatest 
weakness across the included studies were the identification of study perspective (1/6), 
discount rate (1/6), and assumptions applied to the economic analysis (1/6). The highest 
quality reporting was found in the two papers by Williams et al (39, 40) which met 18 and 16 
of the 23 CHEERS criteria, respectively; however, these still fell short in some criteria, 
although different weaknesses were identified in each paper. In contrast, the reporting of the 
economic evaluations by Burton et al (33) and Schabert and Crow (38) only met 5 and 7 of 
the required 23 criteria, respectively.  
DISCUSSION 
This paper represents the first systematic review and critical appraisal of comparative 
effectiveness and health economic research of OMT. The findings point toward an 
insufficient quantity and inadequate quality of comparative effectiveness and cost-




































































findings across a number of areas, including the cost-effective management of low back pain 
(39, 40) and preterm neonate recovery (34), the majority of studies provide incomplete data 
or lack sufficient rigour to be integrated into evidence-based policy decisions (24). Similarly, 
CER suggests OMT may be as effective as standard care for the management of low back 
(42) and neck (47) pain; however, studies need to be replicated in different settings and 
jurisdictions to verify current findings and provide the level of evidence required to inform 
practice change within the broader health system (18). Given the relatively high use of OMT 
amongst individuals with conditions such as back pain (10), as well as the use of OMT by 
pregnant women (9), it is paramount that the abovementioned findings be replicated to 
ensure that clear guidance can be given to these vulnerable populations accessing OMT.  
The high level of heterogeneity across the identified studies significantly limits our ability to 
draw firm conclusions about the comparative effectiveness and economic value of OMT 
when compared with other available health services. This highlights the need for clearer 
guidance on the design, implementation and reporting of osteopathic research. Guidance on 
comparative effectiveness research, for instance, should be attentive to standard research 
reporting requirements (including descriptions of treatment), quality outcome measures, 
appropriate comparator interventions, and suitable blinding and allocation concealment 
procedures. Guidance on economic evaluations, on the other hand, should focus on clearly 
defining the study perspective, discount rate and assumptions of the analysis. These 
recommendations are explored in greater detail in the final section of this discussion. 
The majority of included papers reported results from research conducted in the US. This is 
likely to impact the applicability and generalizability of the findings to other jurisdictions. 
Notably, it is argued that general osteopathic practice in the US is substantially different to 
the rest of the world. This is because osteopathic practitioners in the US are trained as 
physicians before specialising in OMT; by contrast, European and Australasian osteopathic 
training focuses on OMT, and osteopathic training does not result in licensure to practice 




































































of OMT by osteopaths in clinical settings, and as such there may be potential for 
transferability of findings to countries where osteopaths practice as allied health 
professionals or complementary therapists (1, 5). However, there remains a clear need to 
verify the outcomes of these studies in different professional and health care contexts. 
Research gaps and recommendations for future research 
The critical appraisal of included papers highlights the need for increased CER and 
economic analyses in OMT, as well as the replication of such studies; it also alludes to the 
need to improve the quality of future OMT research to ensure findings can inform policy and 
practice. We propose a number of key areas which should be considered in the design of 
future studies of OMT.  
Firstly, researchers need to systematically collect and report the details of OMT used in 
comparative effectiveness studies. Whilst the purpose of pragmatic research is to reflect real 
life practice as closely as possible, documenting and reporting the specific techniques 
utilised in osteopathic research would be highly beneficial for practitioners, educators and 
researchers. Not only would such detailed reporting of osteopathic interventions facilitate the 
translation of research evidence into practice, education and policy, but it would also allow 
inferential statistical analyses to test the potential relationships between specific techniques 
and overall effectiveness of OMT. As such, future osteopathy comparative effectiveness 
research would benefit from complying with intervention reporting guidelines such as the 
Template for Intervention Description and Replication (TIDieR) checklist and guide (50) or 
the CONSORT extension for pragmatic trials (51).  
Secondly, future OMT studies should incorporate more sensitive and nuanced statistical 
analyses. Despite most studies collecting data on important confounding and effect 
modifying variables such as body mass index and gender, few analyses controlled for these 
variables. Similarly, none of the identified CER studies reported analyses of the primary 
results in an attempt to test and verify the key assumptions of the study. For example, if 




































































assumes treatment does not change throughout the study for any one individual and as 
such, their responsiveness to treatment is also consistent. Use of time-dependent regression 
would assist in verifying the validity of the study outcome in this case (52). Similarly, missing 
data, a common feature of comparative effectiveness studies, was not appropriately 
managed within many of these studies. Future studies need to evaluate the extent of 
missing data and its impact on the analysis (52). 
The design and reporting of future economic evaluations of OMT can also be improved. The 
economic perspective of the analysis should be described and justified, i.e. the a priori 
decisions as to whether the ‘cost’ of the intervention will be restricted to government and 
third party funders or will be broadened to include the cost to patients, their families and 
society in general (53). Providing a clearer perspective will enable key stakeholders to make 
rational decisions about the allocation of scarce healthcare resources, such as the allocation 
of funds to support the provision of osteopathic services. Likewise, the currency, price date 
and conversion rate must be included in future economic studies of OMT as this impacts on 
the transferability of the analysis to other jurisdictions, as well as the relevance of the 
findings over time. These issues can be overcome by future research groups undertaking 
studies involving economic evaluations of osteopathy by complying with the CHEERS 
reporting statement (32) when reporting findings.  
CONCLUSIONS 
Comparative effectiveness and health economic studies offer valuable insights into health 
services that can inform evidence-based policy and practice. Despite the diverse regional 
presence of osteopathy and the practice of OMT throughout the world, limited research 
focusing upon OMT has employed either of these study methodologies to date. There is a 
need for researchers and the broader osteopathic community to support the advancement of 
rigorous and robust comparative effectiveness and health economic research that reflects 
osteopathic practice if this area of health care provision is to advance its role and place 
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Figure 1: PRISMA Flow chart for articles reporting comparative effectiveness of osteopathic manipulative treatment 
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Figure 2: PRISMA Flow chart for articles reporting health economic analysis of osteopathic manipulative treatment 
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Table 1: Characteristics of included studies examining the cost or comparative effectiveness of osteopathic manipulative treatment. 
Author 
(Year) 









and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 
 Comparative effectiveness studies 
Andersson 





trial (2 arms) 
Patients (20-















pain scale (0-100); 
Roland-Morris; 
Oswestry 
Follow-up 12 wks: 
No significant difference between 
groups in any primary outcome 
measure. Osteopathic group used less 
medication (analgesics, anti-
inflammatory, muscle relaxants) (P< 
































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 
Licciardone 





trial (3 arms) 
Patients  (18-
















control group. All 
patients were allowed 
to continue their usual 
care for low back pain. 
SF-36;  
10-cm visual 
analog scale for 
overall back pain; 
Roland–Morris;  
Lost work or school 
days because 
of back pain; 
Satisfaction with 
back care 
Follow-up 6 months: 
There were no significant benefits 
with osteopathic manipulative 
treatment, as compared with sham 
manipulation.  
Both active and sham manipulation 
appear to provide some benefits 
when used in addition to usual care 
for the treatment of chronic 
nonspecific low back pain (e.g. greater 
improvements in back pain and 
physical functioning and greater 































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 













months to 12 

























Parents were  
asked: 
“Did you note any 
changes in your 
child as a result of 
the therapies, and 
if so, what were the 
changes?” 
Parents' perception 
of their child’s level 
of muscle stiffness 
and their child’s 
level of happiness 
on 2 separate visual 
log scales, 100 
millimeters in 
length. 
Follow-up 24 wks: 
2 of 17 parents reported positive gains 
while their child was in a wait-list 
control period (but all 17 reported 
gains while in the treatment phase of 
the study; 
Twenty-one of the 23 parents of the 
children in the osteopathic 
group reported improvement in 
their child during the course of 
therapies; 
All of the 19 parents of children in the 
acupuncture group reported 































































and control arms) 
Outcome measures 
and time-points 









trial (2 arms) 
Patients (18 to 













treatment (5 min) 
11-point numerical 
rating scale for pain 
Follow-up one hour post treatment: 
Both groups had significant reduction 
in pain intensity but there was no 
significant difference between the 




2006 Canada Randomised 
controlled 
trial (2 arms) 
Patients (>16 
yrs) recruited 











relaxation plus 3 
osteopathic 
treatments 
Headache diary Follow-up 4 to 5 weeks post 
treatment initiation (6 to 7 wks from 
baseline): 
Number of headache free days/wk 
improved with osteopathy (P = .016). 
There was no significant difference in 































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 























Index (ODI) was the 
primary outcome 
Follow-up 6 wks: 
All three treatments indicated 
comparable reductions in mean (95% 
confidence intervals) ODI: group 
exercise, −4.5 (−0.9 to −8.0); 
physiotherapy, −4.1 (−1.4 to −6.9); 































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 







trial (3 arms) 
Pediatric 
patients (20 
months to 12 























Follow-up 24 wks: 
statistically 
significant improvement in two 
mobility measures for 
patients who received OMT—the total 
score of Gross Motor 
Function Measurement and the 
mobility domain of Functional 
Independence Measure for Children 
(P<.05). No statistically significant 
improvements were seen among 
































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 




















treatment (OMT) plus 
placebo Echinacea; 
OR 
Echinacea plus sham 
OMT; 
OR 




plus Sham OMT) 
Prevention of acute 
otitis media (risk of 
having at least one 
episode of acute 




Follow-up 6 months: 
No interaction was found between 
Echinacea purpurea and OMT. 
E.purpurea was associated with a 
borderline increased risk of having at 
least one episode of acute otitis media 
during 6-month follow-up compared 
to placebo (65% versus 41%; relative 
risk, 1.59, 95% CI 1.04, 2.42). OMT did 
not significantly affect risk compared 
to sham (44% versus 61%; relative 
risk, 0.72, 95% CI 0.48, 1.10). 











Pancreatitis Standard care Length of hospital 
stay 
































































and control arms) 
Outcome measures 
and time-points 
















Chemo-nucleolysis Cost of treatment Cost savings of £300 per patient with 

















Standard GP care Cost of treatment  Increased health care costs (£65) 

















































































and control arms) 
Outcome measures 
and time-points 















Standard care Cost of treatment No difference in total cost per episode 
of care but reduced costs for radiology 


















Cost of treatment Lower cost per office visit compared 
with MD but not compared with DO 



















Length of hospital 
stay 
Length of stay reduced by 5.9 days 
with OMT (p<.0001); reduced cost 
estimates (-€2724.91, p<.0001); no 































































and control arms) 
Outcome measures 
and time-points 
Summary of findings (effectiveness of 
OMT) 













Standard care Length of hospital 
stay 
Length of stay reduced for patients 
having lung decortication (-6.4 days, 




Table 2: Rating of study bias using Cochrane Collaboration risk of bias tool and PRECIS-2 rating of comparative effectiveness studies  

































Low Unclear High High Low Unclear Unclear 33 
Andersson et al 
(42) 




















































Chown et al (43) Low Unclear High High High Unclear Unclear 28 
Duncan et al (44) Unclear Unclear High High Unclear High High 28 
Anderson & 
Seniscal (41) 
Low High High High Unclear High Unclear 26 
Duncan et al (45) Low Low Unclear Low High Unclear High 25 
Wahl et al (48) Low Low Low Low Unclear Unclear Unclear 25 
Licciardone et al 
(46) 





























































et al (42)  
Licciardone 








Seniscal (41)  
Chown et 
al (43)  
Duncan 




Data (D1-D6)         
D1. Details of treatment adequately recorded 
- - - - - - - - 
D2. Primary outcomes adequately recorded  
X X - X X X X - 
D3. Primary clinical outcome(s) measured objectively  
X X - X X X X - 
D4. Primary outcomes validated/ adjudicated 
X X - X X X X - 
D5. Primary outcome(s) measured or identified in an equivalent 
manner between the treatment/intervention group and the 
comparison group(s)  
X X X X n/a X X X 
D6. Important covariates (known confounders/effect modifiers) 
available and recorded X X X X X X X X 
Methods (M1-M5) X X  X  X   
M1. Study population restricted to new initiators of treatment  
X X - X - X - - 
M2. Concurrent comparators or justification of historical 




















































M3. Important covariates/confounding and effect modifying 
variables taken into account in the design and/or analysis X X - X X - - - 
M4. Classification of exposed and unexposed person-time free of 
“immortal time bias” X X X X X X - - 
M5. Meaningful analyses conducted to test key assumptions on 
which primary results are based - - - - - - - - 























































Table 4: Compliance of health economic related osteopathic papers with the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement checklist.* 
Section/item Burton, Tillotson 











Title and abstract       
Title - - X X X - 
Abstract - X X - - - 
Introduction       
Background and objectives - X X X X X 
Methods       
Target population and subgroups X X X X - X 
Setting and location - - X X X X 
Study perspective - - X - - - 
Comparators X X X X X X 
Time horizon - - X X - X 
Discount rate - - X - - - 
Choice of health outcomes - X X - - X 
Measurement of effectiveness - X X - - X 
Estimating resources and costs X  X X X X 
Currency, price date, and conversion - X - - - X 




















































Assumptions - X - - - - 
Analytical methods - X - X - X 
Results       
Study parameters - X X X - X 
Incremental costs and outcomes - X X - - - 
Characterising uncertainty - X X - - - 
Characterising heterogeneity - X X - X - 
Discussion       
Study findings, limitations, generalizability, and current knowledge - X X X X X 
Other       
Source of funding X X - X - X 
Conflicts of interest - - - X - X 
TOTAL (out of 23) 5 16 18 13 7 14 
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indicate which guidelines you have referred to. 
 
These are not quality assessment frameworks and your study need not meet all the criteria 
implied in the reporting guideline to be worthy of publication in the MATH.  The checklists do 
identify essential matters that should be considered and reported upon. For example, a 
controlled trial may or may not be blinded but it is important that the paper identifies whether or 
not participants, clinicians and outcome assessors were aware of treatment assignments. 
 
**You are also required to submit a checklist from the appropriate reporting guideline (available 
on the EQUATOR website (http://www.equator-network.org/) together with your paper as a guide 
to the editors. 
 






























CONSORT – Consolidated Standards of Reporting Trials  
http://www.equator-network.org/reporting-guidelines/consort/  
  
Study of Diagnostic 
accuracy / 
assessment scale 




Systematic Review of 
Controlled Trials 




case control and 
cross sectional 
studies 
STROBE Strengthening the Reporting of Observational Studies in Epidemiology 
http://www.equator-network.org/reporting-guidelines/strobe/  
  
Case Reports CARE  - Case Reports - http://www.care-statement.org/downloads/CAREchecklist-
English.pdf  
  
Statistical reporting SAMPL - guidelines for statistical reporting – no checklist exists currently but authors 
are encouraged to view the guidelines on the EQUATOR website http://www.equator-
network.org/reporting-guidelines/sampl/  
  
 Qualitative researchers might wish to consult the guideline listed below    




Other (please give 
source) 
   
Not applicable 
(please elaborate) 
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